Of the PTC and FTC tumors that became dedifferentiated (so-called radio-iodine (RAI)-refractory), neovascular PSMA expression was reported in 63% of tumors (15/24) [59]. This evidence concerns the gene FOLH1 and thyroid cancer, nonmedullary, 2.